DUROS [trade mark sign] LEUPROLIDE IMPLANTABLE THERAPEUTIC SYSTEMS IN PATIENTS WITH ADVANCED PROSTATE CANCER: 14-MONTH RESULTS OF A PHASE I/II DOSE-RANGING STUDY
1999
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI